Aldeyra Therapeutics Inc (ALDX)
EBITDA Growth
41.74%
Quarterly · Period ending:
ALDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported41.74%period ending
Latest reported41.74%period ending
ALDX Quarterly EBITDA YoY % (143.30% → 41.74%)
Year-over-year change
High-resolution chart · PNG
ALDX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 41.7446% | |
| 68.915% | |
| 61.2327% | |
| 50.9376% | |
| 43.3761% | |
| -24.7522% | |
| -266.076% | |
| -92.1469% | |
| -94.2506% | |
| 50.0382% | |
| 66.2842% | |
| 46.1081% | |
| 51.4893% | |
| 7.734% | |
| 19.0156% | |
| 8.1137% | |
| -19.8785% | |
| -51.9597% | |
| -35.4364% | |
| -84.2588% | |
| -107.3791% | |
| -14.7827% | |
| 10.4047% | |
| 55.466% | |
| 47.5572% | |
| 44.6628% | |
| -19.3966% | |
| -73.3592% | |
| -47.3928% | |
| -102.3041% | |
| -52.5424% | |
| -117.5305% | |
| -70.831% | |
| -65.3459% | |
| -49.7808% | |
| -4.4171% | |
| -23.5879% | |
| -2.4403% | |
| -6.8605% | |
| -42.2808% | |
| -93.7913% | |
| -134.1506% | |
| -79.2188% | |
| -69.2736% | |
| -104.0252% | |
| -449.4816% | |
| -125.6161% | |
| -121.1059% | |
| 30.5496% | |
| 115.2284% | |
| 143.3014% |